A Cyclin-Dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer
PLoS ONE - United States
doi 10.1371/journal.pone.0172315
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 16, 2017
Authors
Publisher
Public Library of Science (PLoS)